28th Annual Student Research Conference
Equity Valuation of Gilead Sciences
Bulldog Student Investment Fund*, Dominic Teoh, David Newell, Zach Wenig, and David Stodden
Prof. Charles Boughton, Faculty Mentor
In our bi-semester research for the Bulldog Student Investment Fund, we have applied both analytical and quantitative approaches to discover the fundamental value of Gilead Corporations equity. Beginning this process we first approached the healthcare sector as a whole, applying different top down analysis to companies that met certain criteria like market cap, price to earnings ratio and being traded on NYSE. After this process, we applied qualitative methods such as: SWOT analysis, Porters Five Forces analysis to Gilead Corporation. Following this we began to combine this research with quantitative methods such as discounted cash flows and Grahams formula to develop a concise price valuation. One of the promising product lines that Gilead has been working on is to cure Hepatitis C, this will provide a strong revenue stream for many years as three percent of the worlds population is thought to have Hepatitis C.Through this research experience we have applied real world valuation techniques to prepare us in the field of finance and investing.
Keywords: Finance, Stock, Gilead Sciences, GILD, Valuation, Equity
Topic(s):Business Administration
Economics
Interdisciplinary
Presentation Type: Oral Paper
Session: 114-3
Location: VH 1328
Time: 8:30